Mesa Laboratories (MLAB)
(Real Time Quote from BATS)
$103.28 USD
+1.48 (1.45%)
Updated Apr 26, 2024 02:46 PM ET
1-Strong Buy of 5 1
B Value F Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/24/24 |
---|---|
Current Quarter | 2.33 |
EPS Last Quarter | 2.02 |
Last EPS Surprise | -0.98% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 8.39 |
Next Year | 9.60 |
EPS (TTM) | 7.64 |
P/E (F1) | 10.60 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 54.80M | 57.20M | 212.10M | 233.70M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 54.80M | 57.20M | 212.10M | 233.70M |
Low Estimate | 54.80M | 57.20M | 212.10M | 233.70M |
Year ago Sales | 55.59M | 50.65M | 219.08M | 212.10M |
Year over Year Growth Est. | -1.42% | 12.93% | -3.19% | 10.18% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.33 | 2.40 | 8.39 | 9.60 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 2.33 | 2.40 | 8.39 | 9.60 |
Low Estimate | 2.33 | 2.40 | 8.39 | 9.60 |
Year ago EPS | 1.94 | 1.77 | 8.33 | 8.39 |
Year over Year Growth Est. | 20.10% | 35.59% | 0.72% | 14.42% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Current | 2.33 | 2.40 | 8.39 | 9.60 |
7 Days Ago | 2.33 | 2.40 | 8.39 | 9.60 |
30 Days Ago | 2.33 | 2.40 | 8.39 | 9.60 |
60 Days Ago | 2.27 | 2.23 | 8.25 | 8.97 |
90 Days Ago | 2.27 | 2.23 | 8.25 | 8.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (3/2024) |
Next Year (3/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.33 | 2.40 | 8.39 | 9.60 |
Zacks Consensus Estimate | 2.33 | 2.40 | 8.39 | 9.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.02 | 1.91 | 1.77 | 1.94 | NA |
Estimate | 2.04 | 1.65 | 1.67 | 1.98 | NA |
Difference | -0.02 | 0.26 | 0.10 | -0.04 | 0.08 |
Surprise | -0.98% | 15.76% | 5.99% | -2.02% | 4.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more